{"id":39932,"date":"2025-09-26T12:41:30","date_gmt":"2025-09-26T10:41:30","guid":{"rendered":"https:\/\/www.qualifyze.com\/?post_type=resources&#038;p=39932"},"modified":"2026-04-09T14:48:27","modified_gmt":"2026-04-09T12:48:27","slug":"new-us-tariffs-a-stress-test-for-global-pharma-supply-chains","status":"publish","type":"resources","link":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/","title":{"rendered":"U.S. Tariffs Impact on Pharma Supply Chains"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Starting October 1, branded pharmaceuticals imported into the U.S. will face a <\/span><b>100 % tariff<\/b><span style=\"font-weight: 400;\">. Generics are excluded \u2014 at least for now. While the announcement is framed as a push for local manufacturing, its impact reaches far beyond U.S. borders. For executives, this policy is not only a financial shock; it is a <\/span><b>stress test of how prepared the industry is to handle disruption<\/b><span style=\"font-weight: 400;\">.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><b>Tariffs Hit Brands, Not Generics (Yet)<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">The exclusion of generics creates a <\/span><b>two-speed market<\/b><span style=\"font-weight: 400;\">:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Branded medicines<\/b><span style=\"font-weight: 400;\"> face doubled import costs, pressuring originator companies to accelerate U.S. manufacturing or risk losing market share.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Generic manufacturers<\/b><span style=\"font-weight: 400;\">, mostly concentrated in India and other low-cost hubs, retain tariff-free access. In the short term, this strengthens their competitive edge in the U.S.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">But the reprieve may be temporary. If tariffs extend to generics, the effect would be even more disruptive, creating <\/span><b>global drug shortages<\/b><span style=\"font-weight: 400;\"> and threatening affordability for patients worldwide.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><b>Strategic Risks for the Pharma Landscape<\/b><\/h2>\n<ol>\n<li><b> Market distortions<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Originator companies may shift resources toward U.S. facilities, reshaping global production flows. Generics could initially expand market share, but they too face uncertainty if political pressure escalates.<\/span><\/li>\n<li><b> Pricing volatility<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Generics\u2019 tariff-free status will likely <\/span><b>drive down branded prices<\/b><span style=\"font-weight: 400;\"> as originators compete to stay relevant. Meanwhile, if generics are later included, patients could face sharp price increases and supply shortages.<\/span><\/li>\n<li><b> Supply concentration risk<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">With generics largely produced in a handful of countries, excluding them now <\/span><b>increases U.S. dependency<\/b><span style=\"font-weight: 400;\"> on those markets. That dependency could become the next policy target \u2014 further destabilizing global supply.<\/span><\/li>\n<li><b> Innovation squeeze<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Originators already face high R&amp;D costs. Tariffs that slash profitability on imports may reduce funds available for innovation, slowing the development of new therapies.<\/span><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<h2><b>What Executives Should Do Now<\/b><\/h2>\n<p><b>Demand visibility across the supply chain<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Executives must know where every component of their portfolio \u2014 branded or generic \u2014 originates. Only with <\/span><b>end-to-end visibility<\/b><span style=\"font-weight: 400;\"> can they model exposure to tariffs, political risk, and compliance issues.<\/span><\/p>\n<p><b>Build dual sourcing and local options<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Whether tariffs remain limited to brands or expand to generics, companies that have <\/span><b>pre-qualified alternative suppliers and regional hubs<\/b><span style=\"font-weight: 400;\"> will adapt faster and avoid last-minute disruptions.<\/span><\/p>\n<p><b>Integrate risk intelligence into strategy<\/b><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Supplier choice should weigh more than cost. <\/span><b>Compliance, geopolitical exposure, and resilience metrics<\/b><span style=\"font-weight: 400;\"> must be part of board-level decision making.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><b>The Bigger Picture<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Exempting generics today may buy policymakers time, but it creates distortions that ripple across the global pharma landscape. <\/span><b>Brands face higher costs, generics enjoy a temporary advantage, and the entire industry faces the risk of future escalation.<\/b><\/p>\n<h2><\/h2>\n<h2><b>Closing Thought<\/b><\/h2>\n<p><span style=\"font-weight: 400;\">The tariff decision is not only about trade policy. It is a <\/span><b>wake-up call for pharmaceutical leadership<\/b><span style=\"font-weight: 400;\">. Transparent and resilient supply chains are the only safe path forward in a world where politics can rewrite the rules overnight.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">At Qualifyze, we help life sciences companies prepare for exactly these scenarios. Through independent audits, supplier intelligence, and risk scoring, we provide the transparency and resilience tools executives need to <\/span><b>turn supply chains from vulnerabilities into competitive advantages<\/b><span style=\"font-weight: 400;\">.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><span style=\"font-weight: 400;\">Visit our Quality Insights Platform to learn how, in only 3 min:<\/span><\/p>\n<p style=\"text-align: center;\"><a class=\"btn-green hidden\" href=\"https:\/\/hubs.ly\/Q03L6S9h0\">Watch 3-minute Demo<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Starting October 1, branded pharmaceuticals imported into the U.S. will face a 100 % tariff. Generics are excluded \u2014 at least for now. While the announcement is framed as a push for local manufacturing, its impact reaches far beyond U.S. borders. For executives, this policy is not only a financial shock; it is a stress [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":39939,"template":"","topic-tags":[77],"resource-type":[51],"class_list":["post-39932","resources","type-resources","status-publish","has-post-thumbnail","hentry","topic-tags-procurement-supply-chain","resource-type-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>U.S. Tariffs Impact on Pharma Supply Chains - Qualifyze<\/title>\n<meta name=\"description\" content=\"Avoid the 3 most common audit mistakes that drain resources and risk compliance. Learn how to strengthen processes and drive continuous improvement.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.qualifyze.com\/es\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Tariffs Impact on Pharma Supply Chains - Qualifyze\" \/>\n<meta property=\"og:description\" content=\"Avoid the 3 most common audit mistakes that drain resources and risk compliance. Learn how to strengthen processes and drive continuous improvement.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/\" \/>\n<meta property=\"og:site_name\" content=\"Qualifyze\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-09T12:48:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2121\" \/>\n\t<meta property=\"og:image:height\" content=\"1414\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/\",\"url\":\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/\",\"name\":\"U.S. Tariffs Impact on Pharma Supply Chains - Qualifyze\",\"isPartOf\":{\"@id\":\"https:\/\/www.qualifyze.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg\",\"datePublished\":\"2025-09-26T10:41:30+00:00\",\"dateModified\":\"2026-04-09T12:48:27+00:00\",\"description\":\"Avoid the 3 most common audit mistakes that drain resources and risk compliance. Learn how to strengthen processes and drive continuous improvement.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#primaryimage\",\"url\":\"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg\",\"contentUrl\":\"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg\",\"width\":2121,\"height\":1414,\"caption\":\"In a futuristic laboratory, a scientist with a pipette analyzes a colored liquid to extract the DNA and molecules in the test tubes. Concept research,biochemistry,immersive technology\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.qualifyze.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Resources\",\"item\":\"https:\/\/www.qualifyze.com\/es\/resources\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"U.S. Tariffs Impact on Pharma Supply Chains\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.qualifyze.com\/es\/#website\",\"url\":\"https:\/\/www.qualifyze.com\/es\/\",\"name\":\"Qualifyze\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.qualifyze.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.qualifyze.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.qualifyze.com\/es\/#organization\",\"name\":\"Qualifyze\",\"url\":\"https:\/\/www.qualifyze.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.qualifyze.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/04\/logo-qualifyze.svg\",\"contentUrl\":\"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/04\/logo-qualifyze.svg\",\"width\":136,\"height\":30,\"caption\":\"Qualifyze\"},\"image\":{\"@id\":\"https:\/\/www.qualifyze.com\/es\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"U.S. Tariffs Impact on Pharma Supply Chains - Qualifyze","description":"Avoid the 3 most common audit mistakes that drain resources and risk compliance. Learn how to strengthen processes and drive continuous improvement.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.qualifyze.com\/es\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/","og_locale":"es_ES","og_type":"article","og_title":"U.S. Tariffs Impact on Pharma Supply Chains - Qualifyze","og_description":"Avoid the 3 most common audit mistakes that drain resources and risk compliance. Learn how to strengthen processes and drive continuous improvement.","og_url":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/","og_site_name":"Qualifyze","article_modified_time":"2026-04-09T12:48:27+00:00","og_image":[{"width":2121,"height":1414,"url":"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/","url":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/","name":"U.S. Tariffs Impact on Pharma Supply Chains - Qualifyze","isPartOf":{"@id":"https:\/\/www.qualifyze.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#primaryimage"},"image":{"@id":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#primaryimage"},"thumbnailUrl":"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg","datePublished":"2025-09-26T10:41:30+00:00","dateModified":"2026-04-09T12:48:27+00:00","description":"Avoid the 3 most common audit mistakes that drain resources and risk compliance. Learn how to strengthen processes and drive continuous improvement.","breadcrumb":{"@id":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#primaryimage","url":"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg","contentUrl":"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/09\/iStock-1395657542.jpg","width":2121,"height":1414,"caption":"In a futuristic laboratory, a scientist with a pipette analyzes a colored liquid to extract the DNA and molecules in the test tubes. Concept research,biochemistry,immersive technology"},{"@type":"BreadcrumbList","@id":"https:\/\/www.qualifyze.com\/new-us-tariffs-a-stress-test-for-global-pharma-supply-chains\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.qualifyze.com\/es\/"},{"@type":"ListItem","position":2,"name":"Resources","item":"https:\/\/www.qualifyze.com\/es\/resources\/"},{"@type":"ListItem","position":3,"name":"U.S. Tariffs Impact on Pharma Supply Chains"}]},{"@type":"WebSite","@id":"https:\/\/www.qualifyze.com\/es\/#website","url":"https:\/\/www.qualifyze.com\/es\/","name":"Qualifyze","description":"","publisher":{"@id":"https:\/\/www.qualifyze.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.qualifyze.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.qualifyze.com\/es\/#organization","name":"Qualifyze","url":"https:\/\/www.qualifyze.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.qualifyze.com\/es\/#\/schema\/logo\/image\/","url":"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/04\/logo-qualifyze.svg","contentUrl":"https:\/\/www.qualifyze.com\/wp-content\/uploads\/2025\/04\/logo-qualifyze.svg","width":136,"height":30,"caption":"Qualifyze"},"image":{"@id":"https:\/\/www.qualifyze.com\/es\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/resources\/39932","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/users\/7"}],"version-history":[{"count":1,"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/resources\/39932\/revisions"}],"predecessor-version":[{"id":43160,"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/resources\/39932\/revisions\/43160"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/media\/39939"}],"wp:attachment":[{"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/media?parent=39932"}],"wp:term":[{"taxonomy":"topic-tags","embeddable":true,"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/topic-tags?post=39932"},{"taxonomy":"resource-type","embeddable":true,"href":"https:\/\/www.qualifyze.com\/es\/wp-json\/wp\/v2\/resource-type?post=39932"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}